147 related articles for article (PubMed ID: 9619708)
1. Risk of endometrial cancer in breast cancer patients under long-term adjuvant treatment with tamoxifen.
Cecchini S; Ciatto S; Bonardi R; Mazzotta A; Pacini P; Muraca MG; Zappa M
Tumori; 1998; 84(1):21-3. PubMed ID: 9619708
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Romero SA; Young K; Hickey M; Su HI
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
4. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for endometrial cancer in women receiving tamoxifen.
Suh-Burgmann EJ; Goodman A
Ann Intern Med; 1999 Jul; 131(2):127-35. PubMed ID: 10419429
[TBL] [Abstract][Full Text] [Related]
6. Should tamoxifen users be screened for endometrial lesions?
Neven P; Vergote I
Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
[No Abstract] [Full Text] [Related]
7. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
8. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-induced endometrial cancer.
Chen P; Yang CC; Chen YJ; Wang PH
Eur J Gynaecol Oncol; 2003; 24(2):135-7. PubMed ID: 12701962
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.
Neri F; Maggino T
Eur J Gynaecol Oncol; 2009; 30(4):357-60. PubMed ID: 19761121
[TBL] [Abstract][Full Text] [Related]
11. Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
Rutqvist LE
J Natl Cancer Inst; 1996 Oct; 88(20):1497-9; author reply, 1497-9. PubMed ID: 8841030
[No Abstract] [Full Text] [Related]
12. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.
Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y
Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460
[TBL] [Abstract][Full Text] [Related]
13. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.
Love CD; Muir BB; Scrimgeour JB; Leonard RC; Dillon P; Dixon JM
J Clin Oncol; 1999 Jul; 17(7):2050-4. PubMed ID: 10561257
[TBL] [Abstract][Full Text] [Related]
14. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
[TBL] [Abstract][Full Text] [Related]
15. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
Barakat RR
J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245
[No Abstract] [Full Text] [Related]
16. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma.
Juneja M; Jose R; Kekre AN; Viswanathan F; Seshadri L
Int J Gynaecol Obstet; 2002 Mar; 76(3):279-84. PubMed ID: 11880131
[TBL] [Abstract][Full Text] [Related]
18. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
[TBL] [Abstract][Full Text] [Related]
19. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen therapy--long-term results and complications.
Moore MP; Kinne DW
Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
[No Abstract] [Full Text] [Related]
[Next] [New Search]